| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |